MATTHEWS ASIA INNOVATORS FUND HKSE:01801 Holdings History
MATTHEWS ASIA INNOVATORS FUND's Innovent Biologics Inc Holding Summary
As of 2025-03-31, MATTHEWS INTERNATIONAL FUNDS held 750,500.00 shares of Innovent Biologics Inc(HKSE:01801), totaling HK$4.52 Mil. This investment constitutes 1.92% of their stock portfolio, and MATTHEWS INTERNATIONAL FUNDS now holds 0.05% of the outstanding Innovent Biologics Inc(HKSE:01801) stock.
The initial trade took place in 2019Q3. And since then MATTHEWS ASIA INNOVATORS FUND has made 10 purchases of HKSE:01801, at an average price of HK$54.04, for a total of 9.34 Mil shares. In addition, there have been 8 sales at an average price of HK$48.19 for 8.59 Mil shares. Based on historical transaction data and HKSE:01801's current price of HK$82.35, MATTHEWS ASIA INNOVATORS FUND's estimated gain on his HKSE:01801 holdings is HK$-28.99 Mil, reflecting a -5.74% gain to date.
MATTHEWS ASIA INNOVATORS FUND HKSE:01801 (HK$82.35) Holding Chart
MATTHEWS ASIA INNOVATORS FUND HKSE:01801 (HK$82.35) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price HK$-/Share | ||
| Shares Sold | 0 | Average Price HK$-/Share | ||
| Current Price HK$0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
